BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $951,010 | -36.1% | 25,199 | -22.8% | 0.26% | -34.5% |
| Q2 2023 | $1,487,716 | +12.1% | 32,654 | -0.2% | 0.40% | +7.8% |
| Q1 2023 | $1,327,488 | -20.7% | 32,729 | -0.3% | 0.37% | -22.4% |
| Q4 2022 | $1,673,294 | -14.6% | 32,829 | -9.8% | 0.48% | -18.0% |
| Q3 2022 | $1,960,000 | -16.4% | 36,396 | -0.3% | 0.58% | -7.9% |
| Q2 2022 | $2,345,000 | -17.5% | 36,511 | -0.3% | 0.63% | -4.4% |
| Q1 2022 | $2,841,000 | -9.8% | 36,636 | -0.1% | 0.66% | -7.2% |
| Q4 2021 | $3,149,000 | +6.7% | 36,686 | -0.0% | 0.71% | -2.5% |
| Q3 2021 | $2,952,000 | -0.4% | 36,702 | -0.3% | 0.73% | 0.0% |
| Q2 2021 | $2,963,000 | -4.7% | 36,812 | -0.2% | 0.73% | -11.0% |
| Q1 2021 | $3,110,000 | +2.6% | 36,870 | -2.4% | 0.82% | -8.7% |
| Q4 2020 | $3,030,000 | +1.1% | 37,760 | +1.3% | 0.90% | -16.4% |
| Q3 2020 | $2,996,000 | -9.4% | 37,260 | -3.0% | 1.08% | -9.1% |
| Q2 2020 | $3,307,000 | +6.0% | 38,410 | 0.0% | 1.18% | -6.2% |
| Q1 2020 | $3,119,000 | -7.2% | 38,410 | -4.5% | 1.26% | +33.2% |
| Q4 2019 | $3,362,000 | -7.0% | 40,200 | -2.7% | 0.95% | -12.6% |
| Q3 2019 | $3,616,000 | +6.8% | 41,335 | 0.0% | 1.08% | +6.7% |
| Q2 2019 | $3,385,000 | -2.9% | 41,335 | -3.6% | 1.02% | -1.5% |
| Q1 2019 | $3,487,000 | +24.7% | 42,885 | +1.0% | 1.03% | +12.8% |
| Q4 2018 | $2,796,000 | -14.8% | 42,479 | -0.2% | 0.91% | +1.7% |
| Q3 2018 | $3,282,000 | +4.4% | 42,579 | 0.0% | 0.90% | -1.0% |
| Q2 2018 | $3,144,000 | +12.4% | 42,579 | -1.0% | 0.91% | +14.9% |
| Q1 2018 | $2,796,000 | +0.2% | 42,989 | -0.4% | 0.79% | +1.7% |
| Q4 2017 | $2,790,000 | +1.2% | 43,164 | -1.8% | 0.78% | +0.1% |
| Q3 2017 | $2,757,000 | +2.8% | 43,934 | -0.8% | 0.78% | -1.0% |
| Q2 2017 | $2,681,000 | +16.7% | 44,284 | 0.0% | 0.78% | +12.2% |
| Q1 2017 | $2,297,000 | +17.8% | 44,284 | +0.7% | 0.70% | +16.1% |
| Q4 2016 | $1,950,000 | -6.9% | 43,984 | 0.0% | 0.60% | -11.1% |
| Q3 2016 | $2,094,000 | +4.0% | 43,984 | -1.2% | 0.68% | -1.0% |
| Q2 2016 | $2,013,000 | +8.6% | 44,509 | -1.3% | 0.68% | +10.0% |
| Q1 2016 | $1,853,000 | +6.2% | 45,099 | -1.4% | 0.62% | +3.0% |
| Q4 2015 | $1,744,000 | +16.0% | 45,724 | -0.1% | 0.60% | +13.1% |
| Q3 2015 | $1,504,000 | -53.1% | 45,774 | -0.1% | 0.53% | -47.7% |
| Q2 2015 | $3,204,000 | +1.6% | 45,814 | -0.4% | 1.02% | +1.0% |
| Q1 2015 | $3,152,000 | -6.4% | 46,014 | +0.2% | 1.01% | -6.9% |
| Q4 2014 | $3,367,000 | +2.8% | 45,940 | +0.7% | 1.09% | -5.5% |
| Q3 2014 | $3,276,000 | -0.3% | 45,640 | +0.4% | 1.15% | +6.2% |
| Q2 2014 | $3,287,000 | +1199.2% | 45,470 | +1221.8% | 1.08% | +1143.7% |
| Q1 2014 | $253,000 | +12.4% | 3,440 | +6.2% | 0.09% | +24.3% |
| Q4 2013 | $225,000 | – | 3,240 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |